Real-world Practical Experience of Angiotensin Receptor-neprilysin Inhibitor in Older Japanese Patients with Chronic Heart Failure

INTRODUCTION: Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is superior to enalapril for chronic heart failure (CHF) with reduced ejection fraction (EF). However, its efficacy and safety in older Japanese patients in clinical practice are poorly understood. We aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Toshinori, Minamisawa, Masatoshi, Okada, Ayako, Motoki, Hirohiko, Kasai, Toshio, Kuwahara, Koichiro, Ikeda, Uichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628264/
https://www.ncbi.nlm.nih.gov/pubmed/37941691
http://dx.doi.org/10.31662/jmaj.2023-0109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628264/
https://www.ncbi.nlm.nih.gov/pubmed/37941691
http://dx.doi.org/10.31662/jmaj.2023-0109

Ejemplares similares